Frontlight ResearchEarly access
Friedreich ataxia trials in Australia
1 of 2 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia
- Where
- East Melbourne, Melbourne, Sydney
- Age
- 18 years to 65 years
- People
- 20
- Run by
- Design Therapeutics, Inc.
See details and how to joinNCT06874010